Rising Prominence CKD Boosts Pharmaceutical Grade Sodium Chloride Production, Says FMI

VALLEY COTTAGE, N.Y. – With growing number of diseases worldwide, demand for proper medication has become immanent, thereby resulting in positive growth of pharmaceutical sector. Globally, about 200 million individuals are diagnosed with chronic kidney disease (CKD). Studies opine that the prevalence of the disease is climbing, and by next two decades, CKD is estimated to emerge as the fifth leading cause of mortality across the globe.

Pharmaceutical grade sodium chloride is garnering huge traction as a constituent of treatments, such as hemodialysis, in addressing chronic kidney disease. In addition, pharmaceutical grade sodium chloride is gaining wide acceptance as a starting substance in multitude of pharmaceutical purposes – ORS formulations, and contact lenses solutions. Influenced by the trend, FMI computes that the global pharmaceutical grade sodium chloride is anticipated to grow at a CAGR of ~6% over the forecast period (2019-2029), surpassing US$ 450 Mn by 2029 end.

Download the sample copy of Report with table of contents and Figures @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6464

Surging Adoption in Hemodialysis

In the wake of rapid lifestyle and consumption pattern across the globe have amplified the risk of lifestyle disorders, including chronic kidney disease (CKD). Individuals in developed countries, including the US, are highly susceptible to CKD, resulting in inflated medical budget. End-stage renal disease (ESRD) is cured either via kidney transplantation or dialysis. On the contrary, kidney transplant incidents are declining due to deficiency of kidney donors. As such, majority of ESRD patients are addressed via dialysis, especially hemodialysis.

Due to sedentary lifestyle in tandem with rising inclination towards junk items, consumers, particularly among millennial, are inching towards the vicinity of diseases, such as cardiovascular diseases (CVD), chronic or late stage CKD, and diarrhea, finds FMI. Such demand situation echoes rising incidents of hemodialysis, thereby fueling the need for pharmaceutical grade sodium chloride.

2019 Analysis and Review of Pharmaceutical Grade Sodium Chloride Market by Type – API-NaCl and HD-NCl for 2019 – 2029:https://www.futuremarketinsights.com/reports/pharmaceutical-grade-sodium-chloride-market

Europe and East Asia at Forefront

FMI suggests that the market of pharmaceutical grade sodium chloride remains lucrative in Europe and East Asia. Around 10% of individuals in Europe are suffering from partial kidney dysfunction, thereby resonating to increased incidents of renal replacement therapies, such as hemodialysis. In a bid to improve outcome transparency within healthcare settings, the European Renal Association – European Dialysis and Tx Association (ERA-EDTA) registry are offering information regarding service providers on the basis of clinical and patient experience for particular diseases.

Similarly, prevalence of CKD is on a rise due to various socio-economic factors. In China, around 120 million individuals are affected by CKD. Despite occurrence of CKD is regardless of age, it is more prominent among geriatrics. India houses an estimated count of 100,000 patients a year diagnosed with end stage kidney disease (ESKD) are reported, which further turn to hemodialysis. Realizing the facts and figures, market players in pharmaceutical grade sodium chloride are eyeing the target regions for enhanced footprint.

Buy this report @ https://www.futuremarketinsights.com/checkout/6464

Analysts Viewpoint:

“As the prevalence of chronic diseases taking charge, particularly in under-developed in developing countries, need for proper treatment becomes quintessential. Further, manufacturers are seeking Good Manufacturing Practice (GMP), and FDA certifications to comply with directions of hygienic production as well as deployment of pharmaceutical grade sodium chloride.”

Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/customization-available/rep-gb-6464

More Related reports from Chemicals & Materials Market Insights:

About Us

Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.

Contact Us
Mr. Abhishek Budholiya
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44-(0)-20-7692-8790 
Sales: sales@futuremarketinsights.com  
Press OfficePress@futuremarketinsights.com  
Blog: Market Research Blog  

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these